Intervention

furosemide

ClinicalTrials.gov intervention label

Clinical trials8

Recruiting0

Common conditions10

Lead sponsors shown8

Clinical trials

8 shown

Postpartum Management of Gestational Hypertensive Disorders Using FurosemideNCT04343235 · 2020-05-01

Bumetanide Versus Furosemide in Heart FailureNCT00372762 · 2011-01-01

The Influence of Furosemide on Fluid Balance and Intra-abdominal Pressure in Critically Ill PatientsNCT01072071 · 2010-02-01

Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart FailureNCT01028170 · 2009-11-01

Physiopathology of Sodium Retention in AcromegalyNCT00531908 · 2007-09-01

Comparison of Long- and Short-acting Diuretics in Congestive Heart FailureNCT00355667 · 2006-06-01

Nephropathy In Type 2 Diabetes and Cardio-renal EventsNCT00535925 · 2005-10-01

Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood PressureNCT00115726 · 2000-09-01

Common conditions

Congestive Heart Failure3 Acromegaly1 Diabetic Nephropathy1 Edema1 Heart Failure1 Hypertension1 Hypertension, Pregnancy-Induced1 Hypotension1 Intra-Abdominal Hypertension1 Renal Insufficiency1

Leading sponsors

Aspirus Heart and Vascular Institute-Research and Education1 Assistance Publique - Hôpitaux de Paris1 Hyogo Medical University1 London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1 University of Calgary1 University of Campania Luigi Vanvitelli1 Wright State University1 Ziekenhuis Netwerk Antwerpen (ZNA)1

Trial status mix

COMPLETED5

TERMINATED1

UNKNOWN1

WITHDRAWN1

Phase mix

PHASE44

NA2

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.